(Alliance News) - US nonfarm payrolls, an interest rate call in Australia, and any fall-out from UK local elections will keep traders on their toes.

The week starts slowly with China, Japan and the UK on holiday.

The earnings season rumbles on, with focus moving to Europe from the US. HSBC, Shell and Diageo are the top UK names reporting. On the continent, Novo Nordisk is the highlight. In the US, AMD, Pfizer and Disney are on the schedule.

The following is a look ahead at the most important economic and corporate events globally in the days ahead.

Top economic events:

Monday 4 May

11:30 AEST Australia private house approvals

Australia RBA meetings begins

China Labor Day. Financial markets in Shanghai and Shenzhen closed.

10:00 CEST eurozone manufacturing PMI

09:50 CEST France manufacturing PMI

09:55 CEST Germany manufacturing PMI

Ireland Bank Holiday. Financial markets closed.

09:45 CEST Italy manufacturing PMI

Japan Greenery Day. Financial markets closed.

11:00 SAST South Africa manufacturing PMI

09:15 CEST Spain manufacturing PMI

UK Early May Bank Holiday. Financial markets closed.

10:00 EDT US factory orders

Tuesday 5 May

09:00 AEST Australia composite PMI

14:30 AEST Australia interest rate decision

15:30 AEST Australia RBA press conference

08:30 EDT Canada trade balance

09:30 EDT Canada composite PMI

China Labor Day. Financial markets in Shanghai and Shenzhen closed.

08:45 CEST France budget balance

Japan Children's Day. Financial markets closed.

08:30 CEST Switzerland CPI

09:00 BST UK new car sales

08:30 EDT US trade balance

09:45 EDT US composite PMI

10:00 EDT US ISM services PMI

10:00 EDT US new home sales

Wednesday 6 May

10:00 EDT Canada Ivey PMI

09:45 CST China composite PMI

10:00 CEST eurozone composite PMI

11:00 CEST eurozone PPI

08:45 CEST France industrial production

09:50 CEST France composite PMI

09:55 CEST Germany composite PMI

12:00 CEST Germany new car registrations

01:01 IST Ireland services PMI

09:45 CEST Italy composite PMI

10:00 CEST Italy retail sales

Japan Constitution Day. Financial markets closed.

09:15 SAST South Africa S&P Global PMI

09:15 CEST Spain composite PMI

09:30 BST UK composite PMI

08:15 EDT US ADP unemployment

10:30 EDT US EIA crude oil stocks

Thursday 7 May

11:30 AEST Australia trade balance

09:30 CEST eurozone construction PMI

11:00 CEST eurozone retail sales

08:45 CEST France trade balance

08:45 CEST France current account

09:30 CEST France construction PMI

08:00 CEST Germany factory orders

09:30 CEST Germany construction PMI

11:00 IST Ireland unemployment

09:30 CEST Italy construction PMI

08:50 JST Japan Bank of Japan meeting minutes

09:00 CEST Switzerland unemployment

09:30 BST UK construction PMI

08:30 EDT US initial jobless claims

10:30 EDT US EIA natural gas stocks

11:00 EDT US consumer inflation expectations

Friday 8 May

08:30 EDT Canada unemployment

08:30 EDT Canada employment change

08:30 EDT Canada average hourly wages

08:00 CEST Germany trade balance

08:00 CEST Germany industrial production

09:30 JST Japan composite PMI

09:00 CEST Spain industrial production

09:00 CEST Switzerland consumer confidence

07:00 BST UK halifax house price index

08:30 EDT US nonfarm payrolls

08:30 EDT US average weekly hours

10:00 EDT US Michigan consumer sentiment index

10:00 EDT US wholesale inventories

Top company events:

Monday 4 May

National Australia Bank Ltd - half year results

Palantir Technologies Inc - Q1 results

UniCredit Spa - Q1 results

Vertex Pharmaceuticals Inc - Q1 results

Tuesday 5 May

Advanced Micro Devices Inc - Q1 results

Amplifon Spa - Q1 results

AXA SA - Q1 results

Banco BPM Spa - Q1 results

Covestro AG - half year results

DuPont de Nemours Inc - Q1 results

Electronic Arts Inc - full year results

Ferrari NV - Q1 results

Fraport AG - Q1 results

Fresenius Medical Care AG - Q1 results

Geberit AG - Q1 results

Hennes & Mauritz AB H&M - AGM

HSBC Holdings PLC - Q1 results

Hugo Boss AG - Q1 results

International Workplace Group PLC - trading statement

Intesa Sanpaolo Spa - Q1 results

Italgas Spa - Q1 results

Leonardo Spa - Q1 results

Logitech International SA - full year results

Match Group Inc - Q1 results

PayPal Holdings Inc - Q1 results

Pfizer Inc - Q1 results

Westpac Banking Corp - half year results

Wednesday 6 May

Ahold Delhaize NV - Q1 results

Alcon Inc - Q1 results

Ameren Corp - Q1 results

Arm Holdings PLC - full year results

BMW AG - Q1 results

BPER Banca Spa - Q1 results

Campari NV - Q1 results

Cencora Inc - half year results

Continental AG - Q1 results

Corteva Inc - Q1 results

Costco Wholesale Corp - trading statement

Daimler Truck Holding AG - Q1 results

Deutsche Lufthansa AG - Q1 results

Diageo PLC - trading statement

DoorDash Inc - Q1 results

Evotec SE - Q1 results

Exelon Corp - Q1 results

FinecoBank Spa - Q1 results

Fresenius SE & Co KGaA - Q1 results

Global Payments Inc - Q1 results

Heidelberg Materials AG - trading statement

HelloFresh SE - Q1 results

Hensoldt AG - Q1 results

Infineon Technologies AG - half year results

Jeronimo Martins SA - Q1 results

Marriott International Inc - Q1 results

Next PLC - trading statement

Novo Nordisk AS - Q1 results

Rational AG - Q1 results

Redcare Pharmacy NV - Q1 results

Renk Group AG - Q1 results

Royal Philips NV - Q1 results

Smith & Nephew PLC - trading statement

Telecom Italia Spa - Q1 results

Tenaris SA - Q1 results

Trainline PLC - full year results

Uber Technologies Inc - Q1 results

Veolia Environnement SA - Q1 results

Vestas Wind Systems AS - Q1 results

Wacker Chemie AG - AGM

Wolters Kluwer NV - trading statement

Zalando SE - Q1 results

Thursday 7 May

Stora Enso AB - Q1 results

Rathbones Group PLC - Q1 results

Mediobanca Spa - Q1 results

Sun Life Financial Inc - Q1 results

Balfour Beatty PLC - trading statement

Swisscom AG - Q1 results

Coca-Cola HBC AG - trading statement

Harbour Energy PLC - trading statement

Intercontinental Hotels Group PLC - trading statement

Lanxess AG - Q1 results

Legrand SA - Q1 results

Henkel AG & Co KGaA - Q1 results

Rheinmetall AG - Q1 results

Siemens Healthineers AG - half year results

Genmab AS - Q1 results

Jungheinrich AG - Q1 results

GN Store Nord AS - Q1 results

JD Sports Fashion PLC - full year results

Fast Retailing Co Ltd Japa- April sales data

Swiss Re AG - Q1 results

ANZ Group Holdings Ltd - half year results

Banca Mediolanum Spa - Q1 results

Aker BP ASA - Q1 results

Vonovia SE - Q1 results

AP Moeller Maersk AS - Q1 results

Acciona SA - Q1 results

Knorr-Bremse AG - Q1 results

Solvay SA - Q1 results

Azimut Holding Spa - Q1 results

Bouygues SA - Q1 results

Pirelli & C Spa - Q1 results

Engie SA - Q1 results

Enel Spa - Q1 results

Nexi Spa - Q1 results

Iveco Group NV - Q1 results

Skanska Ab - Q1 results

Banca Monte Paschi Siena Spa - Q1 results

Essity AB - capital markets day

Citigroup Inc - annual investors day

MercadoLibre Inc - Q1 results

Morgan Sindall Group PLC - trading statement

SUSS MicroTec SE - Q1 results

Airbnb Inc - Q1 results

Wynn Resorts Ltd - Q1 results

Cloudflare Inc - Q1 results

Friday 8 May

Krones AG - Q1 results

Airtel Africa PLC - full year results

Commerzbank AG - Q1 results

Bechtle AG - Q1 results

Clariant AG - Q1 results

Japan Tobacco Inc - Q1 results

Evonik Industries AG - Q1 results

Fresenius Medical Care AG - Q1 financial report

QBE Insurance Group Ltd - Q1 results

Taiwan Semiconductor Manufacturing Co Ltd - monthly sales April

International Consolidated Airlines Group SA - Q1 results

Macquarie Group Ltd - full year results

Nintendo Co Ltd - full year results

NTT Corp - full year results

Sony Group Corp - full year results

Mitsubishi Motors Corp - full year results

Nikon Corp - full year results

Nippon Telegraph & Telephone Corp - full year results

Fidelity National Information Services Inc - Q1 results

Rightmove PLC - trading statement

Here's what to watch for as the week unfolds.

TUESDAY: The Reserve Bank of Australia is expected to raise interest rates by 25 basis points as it grapples with inflationary pressures caused by soaring oil prices. Citi analyst Josh Williamson says the RBA's inflation "headache" is about to "become a migraine" as he forecasts a quarter point rise in the benchmark rate to 4.35% from 4.10%, in line with FXStreet-cited market consensus. Williamson sees inflation pressures broadening on the back of elevated oil prices, with housing related inflation set to accelerate over the coming quarters, along with food and services. As a result, he sees headline inflation around 5.5% by the middle of the year, with trimmed-mean inflation at 3.8%. Therefore, the RBA will likely upwardly revise its inflation forecast in the May Statement on Monetary Policy, and hike by 25bps across May and June for a terminal rate of 4.6%, the Citi analyst says. "The RBA faces a difficult decision, but the persistence of these price shocks necessitates further tightening to manage inflationary expectations," he adds. Bank of America also expects a quarter point hike but says "it's a close call". "Inflation is above target and set to rise further, while the labour market remains too tight. However, the decision will ultimately depend on how the board weighs upside inflation risks against downside growth risks, and we expect this debate will lead to a split decision," BofA says. The broker thinks the case to "front-load" hikes is stronger, as "holding amid rising inflation could feed into expectations, pushing inflation higher".

TUESDAY: RBC Capital Markets thinks "underappreciated competitive pressures" could drive some weakness for three key products at Pfizer. As a result, RBC sits 4% below consensus for first quarter revenue at USD13.35 billion, with consensus at USD13.89 billion. For heart treatment Vyndamax, RBC notes gross pricing has eroded for six consecutive quarters as competitive pressures build. Covid drug Paxlovid faces ongoing demand challenges and a dent from a weaker Covid season, while pneumococcal vaccine Prevnar faces increasing competition from Merck's Capvaxive, the bank points out. This could overshadow anticipated beats for blood thinner Eliquis and cancer drug Xtandi, RBC says. RBC forecasts first quarter EPS of USD0.71 for Pfizer, versus USD0.73 consensus. JPMorgan also flags likely upside at Eliquis, while it suggests a recent USD2.2 billion EU court ruling on Covid drug Comirnaty could lead to a "fairly sizeable tailwind on sales in 2026".

TUESDAY: UBS says Intel's recent commentary around central processing unit demand and outlook bodes well for Advanced Micro Devices results. However, much of that optimism may be reflected in the share price which has shot up 69% in the last month alone. UBS also thinks the Austin, Texas-based chipmaker may have fared better in terms of supply, where Intel continued to flag constraints. "So we think this sets up very well for AMD," UBS says. UBS estimates AMD server CPU growing as much as 80% this year with units up 40% to 45% and pricing up in the 20% range. In February, AMD forecast first quarter revenue of USD9.8 billion plus or minus USD300 million, up 32% year-on-year, at the mid-point. UBS models first quarter revenue and EPS of USD10.06 billion and USD1.38, above consensus of USD9.84 billion and USD1.27. UBS expects second-quarter guidance for revenue of USD11.18 billion and EPS of USD1.66, ahead of USD10.48 billion and USD1.42 consensus.

TUESDAY: Focus at HSBC's first-quarter results will likely be on the impact of the Middle East crisis and any news on the timing of the resumption of share buybacks. AJ Bell points out that, as "one of the most exposed UK banks to the Middle East, with a 31% stake in Saudi Awwal Bank, investors will be alert to commentary on how the war has impacted wealthy investors in the region." In addition, AJB looks for news on how the integration of Hang Seng Bank is going after HSBC assumed full ownership during the quarter. When announcing that deal last October, HSBC said it it would pause or suspend share buybacks for three quarters. JPMorgan expects the bank to resume buybacks in the second quarter of 2026, consistent with guidance. Company-compiled market consensus looks for net operating income of USD18.49 billion for the first quarter, including net interest income of USD11.28 billion. Underlying revenue is forecast of USD18.68 billion, with pretax profit of USD9.59 billion and EPS of USD0.41. Citi expects a strong quarter for wealth management but doesn't expect any updates on targets until the May 19 to 21 investor trip.

WEDNESDAY: Next's first quarter trading update may give an early indication as to whether consumers are steering clear of the UK high street amid surging energy costs. Richard Hunter, at interactive investor says the clothing and homewares retailer is one of the "best run and most respected stocks within the FTSE 100". But Hunter notes the inflationary impact of higher energy prices "threatens to heighten input costs as well as crimp consumer demand". In March, Next forecast full price sales growth of 4.5% for the financial year ending January 2027, including UK growth of 2.2% and international growth of 14%. It forecast annual pretax profit of GBP1.21 billion, broadly flat year-on-year. Peel Hunt notes sales to the Middle East represent around 6% of turnover for Next. "There will clearly be some disruption here, but the more critical impact will be on the supply chain and wider consumer," Peel Hunt says. The broker does not expect Next to be immune from the weaker consumer demand but sees forecasts holding for now. "Comments around consumer are likely to remain cautious, with the risk of disposable income being eroded by rising energy costs, fuel prices, travel costs, and inflationary pressures ahead of peak," Peel Hunt adds.

WEDNESDAY: Derren Nathan, head of equity analysis at Hargreaves Lansdown says Novo Nordisk's first-quarter results will provide a "critical lens" through which to assess whether "bold" strategic actions have managed to revive volume growth. "Price cuts, higher-dose approvals and distribution partnerships for its weight-loss jab, Wegovy, have been key initiatives so far this year," he noted, while the launch of Wegovy in pill form has also been a "particular success". Investors will be keen to see if that momentum continued following the launch of a rival oral medicine by Eli Lilly, HL's Nathan thinks. Company-compiled consensus forecasts adjusted group sales of DKK69.07 billion, with Diabetes sales of DKK45.63 billion, Obesity sales of DKK19.12 billion and Biopharmaceuticals sales of DKK4.54 billion. Within Diabetes, GLP-1s sales are expected to be DKK31.64 billion with Ozempic sales of DKK26.11 billion. Within Obesity, Wegovy sales of DKK17.40 billion are projected. Adjusted operating profit is forecast of DKK28.74 billion. HL's Nathan believes achieving its "modest" full-year guidance, which currently predicts a revenue drop of between 5% to 13% this year, will likely be a key driver of sentiment. Clinical progress is another point of focus, he adds. UBS sees potential for the bottom end of the sales guidance range to be raised, noting the first quarter has seen a strong pick up at the lower price point for Wegovy.

WEDNESDAY: JPMorgan thinks Diageo will report "better-than-feared" third-quarter sales although a decline in organic growth is forecast. London-based Diageo operates in over 180 countries with a portfolio of over 200 brands, including top sellers like Johnnie Walker whisky, Smirnoff vodka, Tanqueray gin, and Guinness stout. In February, the FTSE 100 listing cut its dividend and gave muted sales guidance, forecasting a full-year organic net sales decline of 2% to 3%, compared to "flat to slightly down" before. Diageo has brought in former Tesco boss Dave Lewis, as chief executive, in a bid to revive its fortunes. Lewis said he is looking to have an updated strategy proposal for the board in calendar second quarter before sharing with the market mid-calendar third quarter. Lewis told a staff meeting on Tuesday this will include a strategic push into the ready-to-drink cocktails market, the Financial Times reported. Ahead of the financial third quarter update, JPM adjusted its sales expectations for Diageo. JPM now looks for organic sales to fall 2.2%, raised from a 4.0% decline forecast previously, with volumes down 3.1%. JPM says a "persistently" weak environment in North America, has been partially offset by benefits from Easter phasing in Europe and Chinese New Year in Asia Pacific, continued strong momentum in Africa, and advanced sell-in ahead of the FIFA World Cup in North America this summer. Jefferies forecasts a 2.7% LFL organic sales decline, which it says is below 2.3% consensus. Jefferies says consensus forecasts a 10% LFL drop in North America, 3.9% growth in Europe, and flat sales in Asia Pacific. More optimistically, UBS predicts a 1.9% drop in first quarter LFL organic sales and sees most upside risk in Asia Pacific, Africa and Latin America. Ahead of the update, Diageo received a boost as US President Donald Trump said he is removing tariffs on Scottish whisky. Citi analyst Simon Hales said the move is 1% to 2% accretive to Diageo's consensus EPS on an annualised basis.

THURSDAY: Keep an eye on the pound and UK gilts after local election results out late Thursday and into Friday. With the ruling Labour Party expected to perform poorly, there is speculation of a leadership challenge to Prime Minister Keir Starmer. Bloomberg reported that council seat losses of around the 2,000 mark could lead to further pressure on Starmer, while the Times reported that some Cabinet ministers have set the bar at 1,500 seats. Deutsche Bank says if the May election results are sufficiently bad for the Labour Party as to see a leadership challenge over the summer, it would expect risk premia to remain in place for UK fixed income and the pound. "Whether they widen further will depend on the policy platform of any potential challengers, and actual measures taken thereafter," Deutsche says. The yield on 10-years gilts have risen sharply in the wake of the Middle East crisis, topping 5.00%, after trading closer to 4.20% before. ING thinks borrowing costs could initially climb if the political situation worsens, but says a leadership change need not materially alter the fiscal or Bank of England outlook. ING thinks the scale of Labour's defeat will be key and what drives it. If the situation were to escalate or a leadership contest were to be triggered, the 10-year yield could easily rise another 10 basis points to 20bps, ING says, "in line with the nervousness seen in markets prior to the budget announcement last year."

THURSDAY: A reported boardroom split, and likely weak trading, will be topics of discussion when JD Sports Fashion reports full-year results. The sports retailer recently announced the departure of Chair Andrew Higginson, which the Financial Times said followed a failed attempt by him to oust Chief Executive Regis Schultz. JD Sports denied this, and said Schultz has the "continued" support of the board. For financial 2026, Citi analyst Monique Pollard expects pretax profit of GBP849 million, in line with Visible Alpha consensus, with fourth quarter like-for-like sales down 1.8%. Pollard also expects an update on first trading. Here, the Citi analyst forecasts group LFL sales to decline by 2.1% on year versus VA consensus of down 1.6%. She sees UK LFL sales down 3.7%, Europe down 2.5%, Asia Pacific up 0.5%, and North America down 1.0%, with VA consensus at -3.3%, -1.3%, +0.8% and -1.0%, respectively. "Our forecasts reflect the assumption that the consumer backdrop in UK/Europe remains challenging, and the market backdrop remains highly promotional across all regions," she says. For financial 2027 guidance, Pollard expects pretax profit of GBP832 million.

THURSDAY: Intercontinental Hotels Group is expected to report a strong quarter despite concerns that the Middle East crisis may have hit consumer confidence and reduce travel. IHG owns the Holiday Inn chain and is one of the largest hotel operators in the world with significant exposure to the US. Despite the concerns, analyst expect a strong performance across all regions, bar the Middle East. Bank of America forecasts 3.9% like-for-like revenue per available room growth for the first quarter on a year before and 2.4% for the financial year. BofA points out IHG has a relatively small exposure to the Middle East with just 5% of rooms and current-year openings there. Jefferies also forecasts RevPAR growth of 3.9% for the quarter and looks for an acceleration in the US and confirmation of improving momentum in Greater China. JPMorgan models 3.1% quarterly growth.

THURSDAY: Disney's second earnings provide an opportunity for its new chief executive, Josh D'Amaro, to outline his plans. The Burbank, California-based media and entertainment group announced the promotion of D'Amaro, who was chair of Disney Experiences, in February, succeeding Bob Iger. AJ Bell points out that as the first 'non-content' leader at Disney in decades D'Amaro faces extra scrutiny on the creative side of the business. But AJ Bell thinks the quarter should get a helping hand from a strong release slate including The Devil Wears Prada 2, Mandalorian & Grogu, and Toy Story 5. JPMorgan notes that while investors received a glimpse of D'Amaro's vision from prepared remarks delivered at the annual shareholder meeting, this will be his first earnings call. "We expect Q&A will test the new management team on a range of issues, with particular attention paid to strategic or structural matters, however it would be surprising to see anything substantive out of the gate. Separately, any commentary around Parks will be in focus given the recent macro volatility, in addition to the NFL which appears intent on reopening rights agreements," JPM says. For the quarter, JPM forecasts adjusted EPS of USD1.49 for Disney, versus USD1.46 a year prior and USD1.50 Bloomberg consensus. The broker forecasts revenue of USD25.05 billion versus USD23.62 billion a year ago and USD24.84 billion consensus.

FRIDAY: Non-farm payrolls bring down the curtain on a week of US labour market figures, with job vacancy data, ADP private payrolls figures alongside the weekly jobless claims number. Bloomberg consensus looks for 63,000 job additions in April, slowing markedly from 178,000 in March, with an unchanged unemployment rate of 4.3%. Initial jobless claims fell to their lowest level since 1969 during the week of April 25, which analysts say points to layoffs remaining very low, suggesting the labour market is not weakening markedly. Federal Reserve Chair Jerome Powell has characterised the US jobs market as being in an unusual and uncomfortable balance since people who do not have jobs will have a hard time finding employment due to the slow hiring. April's Beige Book pointed to stable labour demand, with low turnover, minimal layoffs, and hiring mostly for replacement.

FRIDAY: British Airways owner IAG reports first-quarter trading amid turmoil in the industry due to soaring energy costs and likely waning consumer demand for travel. The airline is likely to face questions about fuel supply and costs, trimming of less profitable routes, pricing, and current trading. Aarin Chiekrie, an equity analyst at Hargreaves Lansdown, thinks first quarter numbers should hold up "relatively well", with underlying operating profits forecast to jump around 45% higher to GBP288 million in the traditionally quiet quarter. "Much more important will be the outlook for the rest of the year, and a cautious tone is expected," he says. But he believes IAG is in a better position than most airlines to "stomach the recent challenges thanks to its strong balance sheet and higher margins". He says investors are keen to hear whether there's been any changes to IAG's capacity plans this year, noting the firm has already signposted a 3% cut in 2026.

FRIDAY: The recent BP numbers, with the oil major doubling its first-quarter profit, has led to heightened expectations for the week's results from peer Shell, according to Richard Hunter at interactive investor. "Investors will be looking for updates on trading, margins, and any production issues resulting from the Middle East conflict," he says, while there may also be some change to Shell's more recently conservative capital expenditure, having guided for a range of between USD20 billion and USD22 billion for this year. Earnings are expected to jump reflecting the surge in oil prices. Market consensus compiled by Vara predicts adjusted earnings of USD6.36 billion for the quarter compared to USD5.56 billion a year prior and nearly double USD3.26 billion in the previous quarter. Adjusted earnings before interest, tax, depreciation and amortisation is forecast of USD16.73 billion, cash flow from operating activities of USD2.58 billion and a USD12.48 decrease in working capital. Excluding working capital, cash flow from operating activities is forecast at USD14.81 billion. Shell also may give more details on the USD22 billion acquisition of Canadian company ARC Resources which it is estimated will add 370,000 barrels of oil per day to its portfolio, as well as generating double-digit returns and boosting free cash flow from next year. A USD3.5 billion quarterly buyback should also be on the cards.

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2026 Alliance News Ltd. All Rights Reserved.

HSBC

Senast

91,86

1 dag %

0,00%

1 dag

1 mån

1 år

Novo Nordisk ADR

Senast

42,22

1 dag %

0,00%

Diageo PLC

Senast

14,81

1 dag %

1,05%

HSBC Holdings PLC

Senast

13,43

1 dag %

−0,42%

Novo Nordisk B

Senast

275,85

1 dag %

1,32%

JD Sports Fashion PLC

Senast

0,67

1 dag %

−0,15%

Intercontinental Hotels ADR

Senast

143,88

1 dag %

0,00%

Advanced Micro Devices

Senast

354,49

1 dag %

0,00%

Shell ADR

Senast

90,67

1 dag %

0,00%

Walt Disney

Senast

87,61

1 dag %

1,60%

Pfizer

Senast

22,80

1 dag %

1,15%

Shell Plc

Senast

33,21

1 dag %

−0,12%
Marknadsöversikt

1 DAG %

Senast

1 mån